Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panobinostat +/- Rituximab in Relapsed/Refractory DLBCL
NCT01238692Phase 2Completed
- Start
- Nov 2010
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of panobinostat in diffuse large B-cell lymphoma (DLBCL). Started Nov 2010; status: completed.
02
Drugs
panobinostat
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT01238692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01238692.